跳至主要内容
临床试验/EUCTR2005-001007-18-GB
EUCTR2005-001007-18-GB进行中(未招募)1 期

Reversal of warfarin anticoagulation with oral vitamin K: towards a better management of over-anticoagulation - Reversal of warfarin anticoagulation with oral vitamin K

Royal Victoria Infirmary0 个研究点目标入组 140 人开始时间: 2005年4月18日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
140

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • All over-anticoagulated patients will be eligible to participate if they are receiving warfarin with a target INR range of 2-3, irrespective of the duration of warfarin treatment.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Patients will be excluded if they meet one or more of the following criteria: 1) presence of major bleeding requiring immediate and complete correction of anticoagulation, 2) a history of thromboembolic / major haemorrhagic event in the previous 3 months, 3) the primary reason for anticoagulation is prosthetic heart valve, 4) known sensitivity to vitamin K, 5) liver disease.

研究者

相似试验